virus b hepatitis 中文意思是什麼

virus b hepatitis 解釋
乙型病毒性肝炎
  • virus : n 1 【醫學】病毒；濾過性病原體。2 毒素；毒害。3 惡意，惡毒。4 【計算機】（電腦）病毒〈指擾亂或破...
  • b :
  • hepatitis : n. 【醫學】肝炎。 infectious [serum] hepatitis 傳染性[血清]肝炎。
  1. Research on chronicity of hepatitis b virus infection

    乙型肝炎慢性化相關機制的研究
  2. Time - resolved fluorescence immunoassay ( trfia ) has become one of the hotspots in the field of labeled immunoassay application. hepatitis b is a damage of hepar by the hepatitis b virus. now it is a epidemic disease in our country

    乙型病毒性肝炎（簡稱乙型肝炎）是由乙型肝炎病毒（簡稱乙肝病毒）引起的肝臟炎性損害，是我國當前流行最廣泛、危害最嚴重的一種傳染病。
  3. Expression of nuclear factor kappa b in hepatitis c virus core gene transfected cholangiocarcinoma cells

    95相關的細胞凋亡和免疫調節
  4. Preparation and identification of specific transfer factor for hepatitis b virus

    乙型肝炎特異性轉移因子的制備及鑒定
  5. Protection against synergistic hepatocarcinogenesis of hepatitis b virus expression and aflatoxin b1 by antioxidant 2 - tert - 4 - hydroxyanisole in hbv large envelope transgenic mice

    抗氧化劑對黃麴黴毒素染毒的轉基因小鼠肝腫瘤的防護
  6. Cell immune response induced by hepatitis b virus dna vaccine in mice

    乙肝病毒核酸疫苗誘導小鼠細胞免疫應答的研究
  7. Experimental study on effect of shenling yigan granule in antagonizing duck hepatitis b virus

    參靈益肝顆粒抗乙型肝炎病毒作用的實驗研究
  8. Okamoto h, tsuda f, akohane y, et al. hepatitis b virus with mutation in the e antigen - negative phenotype in carriers with e antibody to e antigen [ j ]. j virol, 1994, 68 : 8102

    王小飛，劉華瑞，王錦蓉，等.乙型肝炎和肝癌患者乙型肝炎病毒前c區1896位點突變的研究[ j ] .中華傳染病雜志， 1996 ， 14 : 11
  9. 2. to establish a neutrajizing - inhabition time - resolved fluoroimmunoassay ( trfia ) of hepatitis b virus e antibody ( hbeab ) and hepatitis b virus core antibody ( hbcab ) based on the competion. the assay ranges of standard cures were 0 - 16ncu / mland 0 - 8ncu / ml. the within - run coefficient variations for standard samples were less than 10 %. compared this method with radioimmunoassay, the sensitivities were 92. 8 % and 93. 3 %

    以中和抑製法建立了乙型肝炎病毒e抗體時間分辨熒光免疫分析法（ hbeab - trfia ）和乙型肝炎病毒核心抗體時間分辨熒光免疫分析法（ hbcab - trfia ） ，標準曲線分析范圍分別為0 - 16ncu ml和0 - 8ncu ml 。
  10. Some patients receiving adefovir dipivoxil ( hepsera ) at the approved dose of 10 mg daily for the treatment of chronic hepatitis b virus ( hbv ) infection have a suboptimal virological response characterized by a slow and moderate decrease in hbv replication

    有些接受阿德福韋核準每天10毫克藥量治療慢性乙肝感染的患者常出現緩慢，中度減低病毒復制的不佳抗病毒效應。
  11. Clinical observation on chronic virus b hepatitis treated by jiedu qushi granule preparation

    解毒祛濕沖劑治療慢性乙型病毒性肝炎的臨床觀察
  12. Experiences of yang shaoshan on treatment of virus b hepatitis

    朱生?辨治慢性萎縮性胃炎經驗
  13. Clinical study in relationship between syndrome differentiation and quantity replication of virus in hepatitis b

    慢性乙型肝炎辨證分型與病毒載量及復制性關系的初步研究
  14. Methods : eight hundred and seventy one cases of chronic virus hepatitis b ( hepatitis b ) with tcm clinical data were analyzed by information entropy method

    方法：將871例乙肝患者的中醫臨床資料按發病季節進行分類，然後統計各個季節不同證候的發生次數，建立評價表，利用信息熵評價方法進行計算和分析。
  15. Professor su lian ' s experience of treating chronic virus b hepatitis

    黎炳南教授治療慢性乙型肝炎經驗
  16. Hepatitis c virus ( hcv ), the etiologic agent responsible for non - a, non - b hepatitis in humans, is a leading cause of chronic liver diseases

    丙型肝炎病毒（ hcv ）是非甲非乙型肝炎的主要病原因子。
  17. The procedure involves the operator piercing the skin of the client with a sharp instrument, causing a breach in the skin integrity. where procedures involving skin penetration are not managed correctly, they have the potential to transmit bacterial and fungal infections, as well as viral infections such as human immunodeficiency virus ( hiv ), hepatitis b and hepatitis c. infected persons may not immediately develop signs or symptoms of the diseases

    皮膚穿刺的程序涉及技術員以利器穿刺顧客的皮膚，破壞皮膚的完整性，如果程序不妥善可導致細菌及真菌感染，與及病毒感染，如後天免疫力缺乏癥病毒（艾滋病） 、乙型肝炎或丙型肝炎，受感染人士的病徵或病狀未必會實時出現，對
  18. The situation of b - hepatitis virus carrying in different occupations

    不同職業人群乙肝病毒攜帶狀況調查
  19. Prof ratziu ： it is true that we don ' t have a lot of drugs that are very powerful anti - virus of hepatitis b, and i think the choice really now has done to those agents we check the most powerful inhibitors effects on hbv replication, and also who offer the least chances of pre - resistance in the next few years

    我們確實沒有很多強有力的對抗乙肝病毒的藥物，同時我認為目前我們通過對最強有效的乙肝病毒復制抑制劑的檢驗而把目標鎖定了那些類型的藥物，而且這些類型的藥物在未來的幾年內出現基線耐藥的幾率會很低。
  20. Development of rapid molecular diagnostic assay for simultaneous screening of human immunodeficiency virus type 1 hiv - 1, hepatitis b virus and hepatitis c virus in blood donations

    發展高速分子診斷測定，以便同時測試捐血者的血液中是否含有1型愛滋病病毒乙型肝炎病毒及丙型肝炎病毒
分享友人
分享到 Line

分享到臉書